Alkermes SEC Filings
NASDAQ: ALKSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
40.61+0.50 (+1.25%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Alkermes filing overview
This page lists 2 recent SEC filings by Alkermes (ALKS), including 2 4. Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
ALKS SEC filings
| Filed | Form | Description | Document |
|---|---|---|---|
| Oct 9, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |
| Oct 9, 2026 | 4 | Statement of changes in beneficial ownership | View on EDGAR |